The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
The genetics and neuropathology of Parkinson’s disease
Open accessAbstract
There has been tremendous progress toward understanding the genetic basis of Parkinson’s disease and related movement disorders. We summarize the genetic, clinical and pathological findings of autosomal dominant disease linked to mutations in SNCA, LRRK2, ATXN2, ATXN3, MAPT, GCH1, DCTN1 and VPS35. We then discuss the identification of mutations in PARK2, PARK7, PINK1, ATP13A2, FBXO7, PANK2 and PLA2G6 genes. In particular we discuss the clinical and pathological characterization of these forms of disease, where neuropathology has been important in the likely coalescence of pathways highly relevant to typical PD. In addition to the identification of the causes of monogenic forms of PD, significant progress has been made in defining genetic risk loci for PD; we discuss these here, including both risk variants at LRRK2 and GBA, in addition to discussing the results of recent genome-wide association studies and their implications for PD. Finally, we discuss the likely path of genetic discovery in PD over the coming period and the implications of these findings from a clinical and etiological perspective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Self-citationAlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Self-citationMulticenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
Self-citationα-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Matsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C. A., Sou, Y.-S., Saiki, S., Kawajiri, S., Sato, F., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910140 · Cited by 1,969
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-221 · Cited by 1,753
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Self-citationMitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705
The mystery of missing heritability: Genetic interactions create phantom heritability
Zuk, O., Hechter, E., Sunyaev, S. R., & Lander, E. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119675109 · Cited by 1,542
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,324
Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Grazia Spillantini, M., Anthony Crowther, R., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,025
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease
Zimprich, A., Benet-Pagès, A., Struhal, W., Graf, E., Eck, S. H., Offman, M. N., Haubenberger, D., Spielberger, S., Schulte, E. C., Lichtner, P., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.008 · Cited by 816
VPS35 mutations in Parkinson disease
Vilariño-Güell, C., Wider, C., Ross, O. A., Dachsel, J. C., Kachergus, J. M., Lincoln, S. J., Soto-Ortolaza, A. I., Cobb, S. A., Wilhoite, G. J., Bacon, J. A., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.001 · Cited by 800
Mapping of a gene for Parkinson's disease to chromosome 4q21-q23
Polymeropoulos, M. H., Higgins, J. J., Golbe, L. I., Johnson, W. G., Ide, S. E., Di Iorio, G., Sanges, G., Stenroos, E. S., Pho, L. T., Schaffer, A. A., et al. (1996) · Science · doi:10.1126/science.274.5290.1197 · Cited by 788 · cited 1×
“genetic lesion to a region on the long arm of chromosome four [101].”
BackgroundA common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17830-1 · Cited by 774
Self-citationA novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., & Hayflick, S. J. (2001) · Nature Genetics · doi:10.1038/ng572 · Cited by 752
Genetic, Clinical, and Radiographic Delineation of Hallervorden–Spatz Syndrome
Hayflick, S. J., Westaway, S. K., Levinson, B., Zhou, B., Johnson, M. A., Ching, K. H. L., & Gitschier, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020817 · Cited by 714
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1
Funayama, M., Hasegawa, K., Kowa, H., Saito, M., Tsuji, S., & Obata, F. (2002) · Annals of Neurology · doi:10.1002/ana.10113 · Cited by 667
LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055509 · Cited by 665
Spira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 627
(2004) · doi:10.1002/ana.10846 · Cited by 614
Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
Aharon-Peretz, J., Rosenbaum, H., & Gershoni-Baruch, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033277 · Cited by 597
Nuytemans, K., Theuns, J., Cruts, M., & Van Broeckhoven, C. (2010) · Human Mutation · doi:10.1002/humu.21277 · Cited by 563
Kachergus, J., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 541
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron
Morgan, N. V., Westaway, S. K., Morton, J. E. V., Gregory, A., Gissen, P., Sonek, S., Cangul, H., Coryell, J., Canham, N., Nardocci, N., et al. (2006) · Nature Genetics · doi:10.1038/ng1826 · Cited by 533
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
Di Fonzo, A., Rohé, C. F., Ferreira, J., Chien, H. F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17829-5 · Cited by 531
Lill, C. M., Roehr, J. T., McQueen, M. B., Kavvoura, F. K., Bagade, S., Schjeide, B.-M. M., Schjeide, L. M., Meissner, E., Zauft, U., Allen, N. C., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002548 · Cited by 529
Self-citationDo, C. B., Tung, J. Y., Dorfman, E., Kiefer, A. K., Drabant, E. M., Francke, U., Mountain, J. L., Goldman, S. M., Tanner, C. M., Langston, J. W., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002141 · Cited by 515
High-Resolution Whole-Genome Association Study of Parkinson Disease
Maraganore, D. M., de Andrade, M., Lesnick, T. G., Strain, K. J., Farrer, M. J., Rocca, W. A., Pant, P. V. K., Frazer, K. A., Cox, D. R., & Ballinger, D. G. (2005) · The American Journal of Human Genetics · doi:10.1086/496902 · Cited by 508
Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease
Maraganore, D. M. (2006) · JAMA · doi:10.1001/jama.296.6.661 · Cited by 508
LRRK2 G2019S as a Cause of Parkinson's Disease in North African Arabs
Lesage, S., Dürr, A., Tazir, M., Lohmann, E., Leutenegger, A.-L., Janin, S., Pollak, P., & Brice, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055540 · Cited by 494
Lewy bodies and parkinsonism in families with parkin mutations
Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn‐Hardy, K., Petrucelli, L., Hussey, J., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1132 · Cited by 485
Self-citationCharacterization of PLA2G6 as a locus for dystonia‐parkinsonism
Paisan‐Ruiz, C., Bhatia, K. P., Li, A., Hernandez, D., Davis, M., Wood, N. W., Hardy, J., Houlden, H., Singleton, A., & Schneider, S. A. (2009) · Annals of Neurology · doi:10.1002/ana.21415 · Cited by 480
Self-citationEdwards, T. L., Scott, W. K., Almonte, C., Burt, A., Powell, E. H., Beecham, G. W., Wang, L., Züchner, S., Konidari, I., Wang, G., et al. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2009.00560.x · Cited by 465
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
Nichols, W. C., Pankratz, N., Hernandez, D., Paisán-Ruíz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17828-3 · Cited by 457
Self-citationGenomewide association study for susceptibility genes contributing to familial Parkinson disease
Pankratz, N., Wilk, J. B., Latourelle, J. C., DeStefano, A. L., Halter, C., Pugh, E. W., Doheny, K. F., Gusella, J. F., Nichols, W. C., Foroud, T., et al. (2009) · Human Genetics · doi:10.1007/s00439-008-0582-9 · Cited by 443
A large kindred with autosomal dominant Parkinson's disease
Golbe, L. I., Di Iorio, G., Bonavita, V., Miller, D. C., & Duvoisin, R. C. (1990) · Annals of Neurology · doi:10.1002/ana.410270309 · Cited by 412
Occurrence of Parkinson's syndrome in type 1 Gaucher disease
Neudorfer, O., Giladi, N., Elstein, D., Abrahamov, A., Turezkite, T., Aghai, E., Reches, A., Bembi, B., & Zimran, A. (1996) · QJM · doi:10.1093/qjmed/89.9.691 · Cited by 401
Fung, H.-C., Scholz, S., Matarin, M., Simón-Sánchez, J., Hernandez, D., Britton, A., Gibbs, J. R., Langefeld, C., Stiegert, M. L., Schymick, J., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70578-6 · Cited by 389
Self-citationThe role of pathogenic DJ‐1 mutations in Parkinson's disease
Abou‐Sleiman, P. M., Healy, D. G., Quinn, N., Lees, A. J., & Wood, N. W. (2003) · Annals of Neurology · doi:10.1002/ana.10675 · Cited by 383
Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q
Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K., & Mizuno, Y. (1998) · Neurology · doi:10.1212/wnl.51.3.890 · Cited by 370
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome
Fonzo, A. D., Dekker, M. C. J., Montagna, P., Baruzzi, A., Yonova, E. H., Guedes, L. C., Szczerbinska, A., Zhao, T., Dubbel-Hulsman, L. O. M., Wouters, C. H., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338144.10967.2b · Cited by 364
α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
Miller, D. W., Hague, S. M., Clarimon, J., Baptista, M., Gwinn-Hardy, K., Cookson, M. R., & Singleton, A. B. (2004) · Neurology · doi:10.1212/01.wnl.0000127517.33208.f4 · Cited by 356
Self-citationLocalization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22.
Wilhelmsen, K. C., Lynch, T., Pavlou, E., Higgins, M., & Nygaard, T. G. (1994) · PubMed · Cited by 347
Spira, P. J., Sharpe, D. M., Halliday, G. M., Cavanagh, J., & Nicholson, G. A. (2001) · PubMed · Cited by 343
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease
Di Fonzo, A., Chien, H. F., Socal, M., Giraudo, S., Tassorelli, C., Iliceto, G., Fabbrini, G., Marconi, R., Fincati, E., Abbruzzese, G., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000260963.08711.08 · Cited by 339
Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes
Bonifati, V., Rohé, C. F., Breedveld, G. J., Fabrizio, E., De Mari, M., Tassorelli, C., Tavella, A., Marconi, R., Nicholl, D. J., Chien, H. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167546.39375.82 · Cited by 338
Tayebi, N. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00071-4 · Cited by 327
DCTN1 mutations in Perry syndrome
Farrer, M. J., Hulihan, M. M., Kachergus, J. M., Dächsel, J. C., Stoessl, A. J., Grantier, L. L., Calne, S., Calne, D. B., Lechevalier, B., Chapon, F., et al. (2009) · Nature Genetics · doi:10.1038/ng.293 · Cited by 320
Khan, N. L., Jain, S., Lynch, J. M., Pavese, N., Abou-Sleiman, P., Holton, J. L., Healy, D. G., Gilks, W. P., Sweeney, M. G., Ganguly, M., et al. (2005) · Brain · doi:10.1093/brain/awh667 · Cited by 317
Self-citationA Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease
International Parkinson's Disease Genomics Consortium (IPDGC), & Wellcome Trust Case Control Consortium 2 (WTCCC2) (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002142 · Cited by 314
How much phenotypic variation can be attributed to parkin genotype?
Lohmann, E., Periquet, M., Bonifati, V., Wood, N. W., De Michele, G., Bonnet, A., Fraix, V., Broussolle, E., Horstink, M. W. I. M., Vidailhet, M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10613 · Cited by 301
Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease
Chartier-Harlin, M.-C., Dachsel, J. C., Vilariño-Güell, C., Lincoln, S. J., Leprêtre, F., Hulihan, M. M., Kachergus, J., Milnerwood, A. J., Tapia, L., Song, M.-S., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.08.009 · Cited by 299
Lynch, T., Sano, M., Marder, K. S., Bell, K. L., Foster, N. L., Defending, R. F., Sima, A. A. F., Keohane, C., Nygaard, T. G., Fahn, S., et al. (1994) · Neurology · doi:10.1212/wnl.44.10.1878 · Cited by 288
SNCA variants are associated with increased risk for multiple system atrophy
Scholz, S. W., Houlden, H., Schulte, C., Sharma, M., Li, A., Berg, D., Melchers, A., Paudel, R., Gibbs, J. R., Simon‐Sanchez, J., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21685 · Cited by 281
Self-citationKr�ger, R., Menezes Vieira-Saecker, A. M., Kuhn, W., Berg, D., M�ller, T., K�hnl, N., Fuchs, G. A., Storch, A., Hungs, M., Woitalla, D., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<611::aid-ana9>3.0.co;2-x · Cited by 277
Concurrence of α-synuclein and tau brain pathology in the Contursi kindred
Duda, J. E., Giasson, B. I., Mabon, M. E., Miller, D. C., Golbe, L. I., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0563-3 · Cited by 274
Ross, O. A., Toft, M., Whittle, A. J., Johnson, J. L., Papapetropoulos, S., Mash, D. C., Litvan, I., Gordon, M. F., Wszolek, Z. K., Farrer, M. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20731 · Cited by 268
PINK1-linked parkinsonism is associated with Lewy body pathology
Samaranch, L., Lorenzo-Betancor, O., Arbelo, J. M., Ferrer, I., Lorenzo, E., Irigoyen, J., Pastor, M. A., Marrero, C., Isla, C., Herrera-Henriquez, J., et al. (2010) · Brain · doi:10.1093/brain/awq051 · Cited by 258
Genome-wide Linkage Analysis of a Parkinsonian-Pyramidal Syndrome Pedigree by 500 K SNP Arrays
Shojaee, S., Sina, F., Banihosseini, S. S., Kazemi, M. H., Kalhor, R., Shahidi, G.-A., Fakhrai-Rad, H., Ronaghi, M., & Elahi, E. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.05.005 · Cited by 258
Paisán‐Ruiz, C., Guevara, R., Federoff, M., Hanagasi, H., Sina, F., Elahi, E., Schneider, S. A., Schwingenschuh, P., Bajaj, N., Emre, M., et al. (2010) · Movement Disorders · doi:10.1002/mds.23221 · Cited by 256
Self-citationClinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations
van de Warrenburg, B. P. C., Lammens, M., Lücking, C. B., Denèfle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A., & Horstink, M. W. I. M. (2001) · Neurology · doi:10.1212/wnl.56.4.555 · Cited by 255
Lewy body Parkinson's disease in a large pedigree with 77Parkin mutation carriers
Pramstaller, P. P., Schlossmacher, M. G., Jacques, T. S., Scaravilli, F., Eskelson, C., Pepivani, I., Hedrich, K., Adel, S., Gonzales-McNeal, M., Hilker, R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20587 · Cited by 247
Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN)
Kurian, M. A., Morgan, N. V., MacPherson, L., Foster, K., Peake, D., Gupta, R., Philip, S. G., Hendriksz, C., Morton, J. E. V., Kingston, H. M., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000310986.48286.8e · Cited by 238
Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA)
Kruer, M. C., Paisán‐Ruiz, C., Boddaert, N., Yoon, M. Y., Hama, H., Gregory, A., Malandrini, A., Woltjer, R. L., Munnich, A., Gobin, S., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22122 · Cited by 236
Self-citationThe UK Parkinson's Disease Consortium and The Wellcome Trust Case Control Consortium 2, Spencer, C. C. A., Plagnol, V., Strange, A., Gardner, M., Paisan-Ruiz, C., Band, G., Barker, R. A., Bellenguez, C., Bhatia, K., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq469 · Cited by 219
Hamza, T. H., Chen, H., Hill-Burns, E. M., Rhodes, S. L., Montimurro, J., Kay, D. M., Tenesa, A., Kusel, V. I., Sheehan, P., Eaaswarkhanth, M., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002237 · Cited by 218
Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S., & Takahashi, H. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<884::aid-mds1019>3.0.co;2-8 · Cited by 212
Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35)
Dick, K. J., Eckhardt, M., Paisán-Ruiz, C., Alshehhi, A. A., Proukakis, C., Sibtain, N. A., Maier, H., Sharifi, R., Patton, M. A., Bashir, W., et al. (2010) · Human Mutation · doi:10.1002/humu.21205 · Cited by 202
Self-citationHereditary form of parkinsonism—dementia
Muenter, M. D., Forno, L. S., Hornykiewicz, O., Kish, S. J., Maraganore, D. M., Caselli, R. J., Okazaki, H., Howard, F. M., Snow, B. J., & Calne, D. B. (1998) · Annals of Neurology · doi:10.1002/ana.410430612 · Cited by 201
Gaucher Disease and Parkinsonism: A Phenotypic and Genotypic Characterization
Tayebi, N., Callahan, M., Madike, V., Stubblefield, B. K., Orvisky, E., Krasnewich, D., Fillano, J. J., & Sidransky, E. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3201 · Cited by 200
The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations
Goker-Alpan, O., Lopez, G., Vithayathil, J., Davis, J., Hallett, M., & Sidransky, E. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1353 · Cited by 199
Genetic Variants of the α-Synuclein Gene SNCA Are Associated with Multiple System Atrophy
Al-Chalabi, A., Dürr, A., Wood, N. W., Parkinson, M. H., Camuzat, A., Hulot, J.-S., Morrison, K. E., Renton, A., Sussmuth, S. D., Landwehrmeyer, B. G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007114 · Cited by 198
Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese
Gwinn–Hardy, K., Chen, J. Y., Liu, H.-C., Liu, T. Y., Boss, M., Seltzer, W., Adam, A., Singleton, A., Koroshetz, W., Waters, C., et al. (2000) · Neurology · doi:10.1212/wnl.55.6.800 · Cited by 197
Self-citationATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation
Schneider, S. A., Paisan‐Ruiz, C., Quinn, N. P., Lees, A. J., Houlden, H., Hardy, J., & Bhatia, K. P. (2010) · Movement Disorders · doi:10.1002/mds.22947 · Cited by 189
Self-citationWszolek, Z. K., Pfeiffer, R. F., Bhatt, M. H., Schelper, R. L., Cordes, M., Snow, B. J., Rodnitzky, R. L., Wolters, E. C., Arwert, F., & Calne, D. B. (1992) · Annals of Neurology · doi:10.1002/ana.410320303 · Cited by 187
Genome-wide association study confirms extant PD risk loci among the Dutch
Simón-Sánchez, J., van Hilten, J. J., van de Warrenburg, B., Post, B., Berendse, H. W., Arepalli, S., Hernandez, D. G., de Bie, R. M. A., Velseboer, D., Scheffer, H., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.254 · Cited by 181
Self-citationProgression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study
Khan, N. L. (2002) · Brain · doi:10.1093/brain/awf237 · Cited by 160
Thomas, M., Hayflick, S. J., & Jankovic, J. J. (2004) · Movement Disorders · doi:10.1002/mds.10650 · Cited by 151
Expanding the clinical phenotype of SNCA duplication carriers
Nishioka, K., Ross, O. A., Ishii, K., Kachergus, J. M., Ishiwata, K., Kitagawa, M., Kono, S., Obi, T., Mizoguchi, K., Inoue, Y., et al. (2009) · Movement Disorders · doi:10.1002/mds.22682 · Cited by 147
Hereditary Mental Depression and Parkinsonism With Taurine Deficiency
Perry, T. L., Bratty, P. J. A., Hansen, S., Kennedy, J. L., Urquhart, N., & Dolman, C. L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490440058009 · Cited by 141
Role of parkin mutations in 111 community‐based patients with early‐onset parkinsonism
Kann, M., Jacobs, H., Mohrmann, K., Schumacher, K., Hedrich, K., Garrels, J., Wiegers, K., SCHWINGER, E., Pramstaller, P. P., Breakefield, X. O., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10179 · Cited by 141
Lesage, S., Leutenegger, A., Ibáñez, P., Janin, S., Lohmann, E., Dürr, A., & Brice, A. (2005) · The American Journal of Human Genetics · doi:10.1086/432422 · Cited by 135
Profile of families with parkinsonism‐predominant spinocerebellar ataxia type 2 (SCA2)
Furtado, S., Payami, H., Lockhart, P. J., Hanson, M., Nutt, J. G., Singleton, A., Singleton, A., Bower, J., Utti, R. J., Bird, T. D., et al. (2004) · Movement Disorders · doi:10.1002/mds.20074 · Cited by 132
Self-citationParkin variants in North American Parkinson's disease: Cases and controls
Lincoln, S., Maraganore, D. M., Lesnick, T. G., Bounds, R., de Andrade, M., Bower, J. H., Hardy, J., & Farrer, M. J. (2003) · Movement Disorders · doi:10.1002/mds.10601 · Cited by 131
Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Wider, C. W., Dickson, D. W., & Wszołek, Z. K. (2010) · Neurodegenerative Diseases · doi:10.1159/000289232 · Cited by 128
Kruer, M. C., Hiken, M., Gregory, A., Malandrini, A., Clark, D., Hogarth, P., Grafe, M. R., Hayflick, S. J., & Woltjer, R. L. (2011) · Brain · doi:10.1093/brain/awr042 · Cited by 126
Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson’s disease
Bardien, S., Lesage, S., Brice, A., & Carr, J. A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.11.008 · Cited by 124
Hasegawa, K., Stoessl, A. J., Yokoyama, T., Kowa, H., Wszołek, Z. K., & Yagishita, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.07.010 · Cited by 118
Clinical and positron emission tomography of Parkinson's disease caused by LRRK2
Hernandez, D. G., Paisán‐Ruiz, C., McInerney-Leo, A. M., Jain, S., Meyer‐Lindenberg, A., Evans, E. W., Berman, K. F., Johnson, J. O., Auburger, G. W. J., Schäffer, A. A., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20401 · Cited by 116
Self-citationHeterozygous parkin point mutations are as common in control subjects as in Parkinson's patients
Kay, D. M., Moran, D., Moses, L., Poorkaj, P., Zabetian, C. P., Nutt, J. G., Factor, S. A., Yu, C., Montimurro, J. S., Keefe, R. G., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21039 · Cited by 116
Parkin-positive autosomal recessive juvenile parkinsonism with α-synuclein-positive inclusions
Sasaki, S., Shirata, A., Yamane, K., & Iwata, M. (2004) · Neurology · doi:10.1212/01.wnl.0000134657.25904.0b · Cited by 114
Heritability of Parkinson disease in Swedish twins: a longitudinal study
Wirdefeldt, K., Gatz, M., Reynolds, C. A., Prescott, C. A., & Pedersen, N. L. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.017 · Cited by 113
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
Gaig, C., Martı́, M. J., Ezquerra, M., Rey, M. J., Cardozo, A., & TOLOSA, E. S. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.107904 · Cited by 112
Latourelle, J. C., Sun, M., Lew, M., Suchowersky, O., Klein, C., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., Watts, R. L., et al. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-32 · Cited by 105
Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease
Choi, J. M., Woo, M. S., Ma, H., Kang, S. Y., Sung, Y. H., Yong, S. W., Chung, S. J., Kim, J., Shin, H., Lyoo, C. H., et al. (2008) · Neurogenetics · doi:10.1007/s10048-008-0138-0 · Cited by 101
G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort
Brás, J., Guerreiro, R. J., Ribeiro, M. H., Januário, C., Morgadinho, A., Oliveira, C. R., Cunha, L., Hardy, J., & Singleton, A. (2005) · Movement Disorders · doi:10.1002/mds.20682 · Cited by 99
Self-citationHernandez, D. G., Ruiz, C. P., Crawley, A., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.044 · Cited by 98
PARK9 -LINKED PARKINSONISM IN EASTERN ASIA: MUTATION DETECTION IN ATP13A2 AND CLINICAL PHENOTYPE
Ning, Y., Kanai, K., Tomiyama, H., Li, Y., Funayama, M., Yoshino, H., Sato, S., Asahina, M., Kuwabara, S., Takeda, A., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000310427.72236.68 · Cited by 96
Parkinson's disease and dementia with Lewy bodies: a difference in dose?
Singleton, A., & Gwinn, K. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17117-1 · Cited by 87
Self-citationCLINICOPATHOLOGIC STUDY OF A SNCA GENE DUPLICATION PATIENT WITH PARKINSON DISEASE AND DEMENTIA
Obi, T., Nishioka, K., Ross, O. A., Terada, T., Yamazaki, K., Sugiura, A., Takanashi, M., Mizoguchi, K., Mori, H., Mizuno, Y., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000299387.59159.db · Cited by 85
SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia
Paisán‐Ruiz, C., Doğu, O., Yilmaz, A., Houlden, H., & Singleton, A. (2008) · Neurology · doi:10.1212/01.wnl.0000294327.66106.3d · Cited by 80
Self-citationWhole gene deletion and splicing mutations expand thePINK1 genotypic spectrum
Marongiu, R., Brancati, F., Antonini, A., Ialongo, T., Ceccarini, C., Scarciolla, O., Capalbo, A., Benti, R., Pezzoli, G., Dallapiccola, B., et al. (2006) · Human Mutation · doi:10.1002/humu.9472 · Cited by 76
ATP13A2 variants in early‐onset Parkinson's disease patients and controls
Djarmati, A., Hagenah, J. M., Reetz, K., Winkler, S., Behrens, M. I., Pawlack, H., Lohmann, K., Ramírez, A., Tadić, V., Brüggemann, N., et al. (2009) · Movement Disorders · doi:10.1002/mds.22728 · Cited by 74
Subramony, S. H., Hernandez, D. G., Adam, A., Smith‐Jefferson, S., Hussey, J., Gwinn, K. A., Lynch, T., McDaniel, O. D., Hardy, J., Farrer, M. J., et al. (2002) · Movement Disorders · doi:10.1002/mds.10241 · Cited by 73
Self-citationNeuropathology of Parkinson's disease with the R1441G mutation in LRRK2
Martí-Massó, J. F., Ruiz‐Martínez, J., Bolaño, M. J., Ruiz, I., Gorostidi, A., Moreno, F., Ferrer, I., & de Munaín, A. L. (2009) · Movement Disorders · doi:10.1002/mds.22677 · Cited by 72
Variable expression of neurofibromatosis 1 in monozygotic twins
Rieley, M. B., Stevenson, D. A., Viskochil, D. H., Tinkle, B. T., Martin, L. J., & Schorry, E. K. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33851 · Cited by 69
Wiest, V., Eisenbarth, I., Schmegner, C., Krone, W., & Assum, G. (2003) · Human Mutation · doi:10.1002/humu.10272 · Cited by 65
Mutations in LRRK2 as a Cause of Parkinson’s Disease
Giasson, B. I., & Deerlin, V. M. V. (2007) · Neurosignals · doi:10.1159/000109764 · Cited by 59
Ballana, E., Govea, N., de Cid, R., García, C. B., Arribas, C., Rosell, J., & Estivill, X. (2007) · Human Mutation · doi:10.1002/humu.20639 · Cited by 53
Kin‐cohort analysis of LRRK2‐G2019S penetrance in Parkinson's disease
Goldwurm, S., Tùnesi, S., Tesei, S., Zini, M., Sironi, F. M., Primignani, P., Magnani, C., & Pezzoli, G. (2011) · Movement Disorders · doi:10.1002/mds.23807 · Cited by 51
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism
Criscuolo, C., Volpe, G., Rosa, A. D., Varrone, A., Marongiu, R., Mancini, P., Salvatore, E., Dallapiccola, B., Filla, A., Valente, E. M., et al. (2006) · Movement Disorders · doi:10.1002/mds.20933 · Cited by 49
PINK1 mutation in Taiwanese early-onset parkinsonism
Weng, Y.-H., Chou, Y. W., Wu, W.-S., Lin, K., Chang, H., Yen, T., Chen, R., Wey, S., & Lu, C. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0534-7 · Cited by 45
Gwinn, K. A., Devine, M. J., Jin, L., Johnson, J. O., Bird, T. D., Muenter, M. D., Waters, C., Adler, C. H., Caselli, R. J., Houlden, H., et al. (2011) · Movement Disorders · doi:10.1002/mds.23776 · Cited by 40
Self-citationPaisán‐Ruiz, C., Nath, P., Wood, N. W., Singleton, A., & Houlden, H. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02247.x · Cited by 36
Self-citationPaisán‐Ruiz, C., Scopes, G., Lee, P. J., & Houlden, H. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30929 · Cited by 32
Self-citationPrasad (1999) · doi:10.1002/(sici)1096-8652(199907)61:3
Cited by
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
Mitochondrial dynamics and inheritance during cell division, development and disease
Mishra, P., & Chan, D. C. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3877 · Cited by 1,043
Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
Rocha, E. M., De Miranda, B., & Sanders, L. H. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.004 · Cited by 762
Parkinson disease: from pathology to molecular disease mechanisms
Dexter, D. T., & Jenner, P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.018 · Cited by 707
Ge, P., Dawson, V. L., & Dawson, T. M. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00367-7 · Cited by 496
Metadata
- Authors
- Houlden, H., & Singleton, A. B.
- Venue
- Acta Neuropathologica
- Published
- 2012-07-18
- Volume
- 124
- Issue
- 3
- Pages
- 325-338
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2024349542
- Cited by
- 316
- References
- 135
- FWCI
- 20.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.